Plenty of Evidence for Recombination in SARS-CoV-2
Plenty of Evidence for Recombination in SARS-CoV-2
Different variants of the virus behind the COVID-19 pandemic are swapping chunks of genetic material, but it’s not yet clear what implications that may have for public health.
Plenty of Evidence for Recombination in SARS-CoV-2
Plenty of Evidence for Recombination in SARS-CoV-2

Different variants of the virus behind the COVID-19 pandemic are swapping chunks of genetic material, but it’s not yet clear what implications that may have for public health.

Different variants of the virus behind the COVID-19 pandemic are swapping chunks of genetic material, but it’s not yet clear what implications that may have for public health.

variant
WHO Updates the Nomenclature of SARS-CoV-2 Variants
WHO Updates the Nomenclature of SARS-CoV-2 Variants
Lisa Winter | Jun 1, 2021
Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.
Coronavirus Mutations Could Muddle COVID-19 PCR Tests
Coronavirus Mutations Could Muddle COVID-19 PCR Tests
Jack J. Lee | May 17, 2021
Researchers find that SARS-CoV-2 variants can evade primer-probe sets and recommend that diagnostic assays include multiple targets for reliability.
What Scientists Know About the B.1.617 Coronavirus Variant
What Scientists Know About the B.1.617 Coronavirus Variant
Shawna Williams | May 3, 2021
While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
What Pseudoviruses Bring to the Study of SARS-CoV-2
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Asher Jones | Feb 16, 2021
B.1.525 shares a mutation with the B.1.351 variant first detected in South Africa that seems to allow the virus to dodge the immune system.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Chris Baraniuk | Feb 4, 2021
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021
Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
What’s Ahead for SARS-CoV-2 Research in 2021
What’s Ahead for SARS-CoV-2 Research in 2021
Shawna Williams | Jan 8, 2021
From new treatments to an investigation into the virus’s origins, here are some of the developments we can expect this year.
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Kerry Grens | Jan 8, 2021
An engineered coronavirus with the N501Y mutation—one of many mutations present in the emerging B.1.1.7 and 501.V2 variants of the coronavirus—is neutralized by the sera of COVID-19 vaccine recipients.